Back
ESC Premium Access

Novel biomarker algorithmic panel measuring permutations of immune response to cardiac endothelial injury and global risk factors identifies patients at risk of acute coronary syndrome (ACS)

Session: Poster Session 2 - Acute Coronary Syndromes: Biomarkers
Topic: Biomarkers
Speaker: Professor D. Harrington (Irvine, US)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Douglas Harrington

GuardaHeart Foundation, Irvine (United States of America)
0 follower

6 more presentations in this session

Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study

Speaker: Doctor Z. Zhao (Fuzhou, CN)

Access
Thumbnail

Plasma proteomics in healthy individuals predict myocardial infarction

Speaker: Ms R. Hoogeveen (Amsterdam, NL)

Access
Abstract
Thumbnail

The protein APRIL predicts adverse outcomes in DAPT patients better than NT-proBNP and troponin

Speaker: Professor C. Pemberton (Christchurch, NZ)

Access
Abstract
Thumbnail

GLP-1 levels predict cardiovascular risk in patients with acute myocardial infarction

Speaker: Doctor M. Lehrke (Aachen, DE)

Access
Abstract
Thumbnail

The novel small leucin-rich repeat protein podocan is an independent predictor of major adverse cardiac events in patients with angiographically-defined coronary artery disease

Speaker: Doctor K. watthanasuntorn (Cooperstown, US)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 2 - Acute Coronary Syndromes: Biomarkers

Speakers: Professor D. Harrington, Doctor Z. Zhao, Ms R. Hoogeveen, Professor C. Pemberton, Doctor M. Lehrke...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb